Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.
暂无分享,去创建一个
Walter J Curran | Hak Choy | W. Curran | H. Choy | C. Belani | C. Scott | Chandra P Belani | P. Bonomi | Phil Bonomi | Charles Scott | Patrick Travis | John Haluschak | J. Haluschak | P. Travis
[1] J. Herndon,et al. Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Thomas J. Smith,et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Mehta,et al. O-125 ECOG 2597: Phase III study of induction chemotherapy followed by standard thoracic radiotherapy (STD TRT) vs hyperfractionated accelerated radiotherapy (HART) for patients with unresectable stage III A & B non-small cell lung cancer , 2003 .
[4] J. Herndon,et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] E. Vokes. Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer. , 2001, The oncologist.
[6] J. Doroshow,et al. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] W. Curran,et al. Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 , 2000 .
[8] H. Choy,et al. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study). , 2000, International journal of radiation oncology, biology, physics.
[9] W. Curran,et al. Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group , 2000 .
[10] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] H. Choy,et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] E. Vokes,et al. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] R. Day,et al. 242 Promising long term outcome of weekly paclitaxel and carboplatin with simultaneous thoracic radiotherapy (TRT) for locally advanced non-small cell lung cancer (NSCLC) , 1997 .
[14] J. Herndon,et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. , 1996, Journal of the National Cancer Institute.
[15] M. I. Saunders,et al. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee. , 1996, British Journal of Cancer.
[16] B. Jeremic,et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] B. Jeremic,et al. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] W. Curran,et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. , 1995, Journal of the National Cancer Institute.
[19] H. Bartelink,et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.
[20] R. Arriagada,et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. , 1992, Journal of the National Cancer Institute.
[21] S. Dische,et al. Experience with CHART. , 1991, International journal of radiation oncology, biology, physics.
[22] G. Cable,et al. Everyone's Guide to Cancer Therapy , 1991 .
[23] K. Propert,et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. , 1990, The New England journal of medicine.
[24] C. Perez,et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. , 1990, Annals of internal medicine.
[25] E Wiltshaw,et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] C. Perez,et al. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. , 1986, International journal of radiation oncology, biology, physics.
[27] C. Perez,et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non‐oat cell carcinoma of the lung. Report by the radiation therapy oncology group , 1982, Cancer.